Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

aTYR PHARMA (ATYR) Asset Utilization Ratio (2019 - 2025)

aTYR PHARMA's Asset Utilization Ratio history spans 7 years, with the latest figure at 0.0 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio fell 23.69% year-over-year to 0.0; the TTM value through Dec 2025 reached 0.0, down 23.69%, while the annual FY2025 figure was 0.0, 7.37% down from the prior year.
  • Asset Utilization Ratio reached 0.0 in Q4 2025 per ATYR's latest filing, up from 0.0 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.11 in Q4 2022 to a low of 0.0 in Q3 2025.
  • Average Asset Utilization Ratio over 5 years is 0.04, with a median of 0.01 recorded in 2021.
  • Peak YoY movement for Asset Utilization Ratio: tumbled 97.35% in 2023, then dropped 13.19% in 2024.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.02 in 2021, then surged by 355.97% to 0.11 in 2022, then crashed by 97.35% to 0.0 in 2023, then fell by 13.19% to 0.0 in 2024, then decreased by 23.69% to 0.0 in 2025.
  • Per Business Quant, the three most recent readings for ATYR's Asset Utilization Ratio are 0.0 (Q4 2025), 0.0 (Q3 2025), and 0.0 (Q4 2024).